How large is the protein crystallization market?

In 2027 the market for protein crystallization is worth approximately USD 1.29 billion.

What is the expected industry size of protein crystallization by 2036?

Protein Crystallization Market size was worth USD 1.2 billion in 2026 and is expected to grow at a 8.65% CAGR between 2027 and 2036, attaining USD 2.75 billion by 2036.

How are biologics development and structural biology programs driving demand for protein crystallization in drug discovery?

Increasing reliance on protein structure insights in biologics development is strengthening crystallization use in target validation and drug discovery workflows. Pharmaceutical and biotechnology firms depend on screening kits and reproducible crystallization tools integrated into iterative research pipelines.

How are advanced crystallization techniques and software tools transforming laboratory workflows?

Cell-free crystallization methods and expanding software and services adoption are improving workflow efficiency, data handling, and screening outcomes. These tools help researchers optimize experiments, manage complex datasets, and increase success rates in high-throughput protein crystallization studies.

Why do pharmaceutical and biotechnology companies lead the protein crystallization market?

Pharmaceutical and biotechnology companies held a 65.57% share in 2026 because they routinely use protein crystallization in drug discovery, structural biology, and biologics development through continuous laboratory workflows.

Why are software & services the fastest-growing product segment in the protein crystallization market?

Software & services are growing fastest as laboratories seek better experiment optimization, efficient data management, and improved crystal screening outcomes while reducing manual effort in complex workflows.

Why does North America dominate the protein crystallization market?

North America leads the market through its strong life sciences research ecosystem, concentration of pharmaceutical and biotechnology companies, and routine integration of crystallization into drug discovery and biologics development.

What factors are accelerating protein crystallization market growth in Asia Pacific?

Asia Pacific is expected to expand at a 9.38% CAGR, supported by growing biopharmaceutical research, expanding laboratory infrastructure, and wider adoption of advanced protein analysis technologies.

Who holds a significant market share in the protein crystallization landscape?

Prominent companies in the protein crystallization market include Rigaku Corporation (Japan), FORMULATRIX, Inc. (United States), Mettler-Toledo International Inc. (United States), Corning Incorporated (United States), Greiner Bio-One International GmbH (Austria), Hampton Research Corporation (United States), Bruker Corporation (United States), Molecular Dimensions Limited (United Kingdom), Jena Bioscience GmbH (Germany), Thermo Fisher Scientific Inc. (United States).